These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 34011405)
21. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. West NR; Murray JI; Watson PH Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474 [TBL] [Abstract][Full Text] [Related]
22. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Geethadevi A; Nair A; Parashar D; Ku Z; Xiong W; Deng H; Li Y; George J; McAllister DM; Sun Y; Kadamberi IP; Gupta P; Dwinell MB; Bradley WH; Rader JS; Rui H; Schwabe RF; Zhang N; Pradeep S; An Z; Chaluvally-Raghavan P Cancer Res; 2021 Oct; 81(20):5336-5352. PubMed ID: 34380633 [TBL] [Abstract][Full Text] [Related]
23. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo. Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693 [TBL] [Abstract][Full Text] [Related]
24. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer. Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417 [TBL] [Abstract][Full Text] [Related]
25. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Tomko LA; Hill RC; Barrett A; Szulczewski JM; Conklin MW; Eliceiri KW; Keely PJ; Hansen KC; Ponik SM Sci Rep; 2018 Aug; 8(1):12941. PubMed ID: 30154546 [TBL] [Abstract][Full Text] [Related]
26. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140 [TBL] [Abstract][Full Text] [Related]
27. Oncostatin M pathway plays a major role in the renal acute phase response. Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344 [TBL] [Abstract][Full Text] [Related]
28. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420 [TBL] [Abstract][Full Text] [Related]
30. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas. Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353 [TBL] [Abstract][Full Text] [Related]
31. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239 [TBL] [Abstract][Full Text] [Related]
32. LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer. Zhu G; Wang L; Meng W; Lu S; Cao B; Liang X; He C; Hao Y; Du X; Wang X; Li L; Li L Theranostics; 2021; 11(19):9198-9216. PubMed ID: 34646366 [TBL] [Abstract][Full Text] [Related]
33. Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway. Zeng R; Zhang D; Zhang J; Pan Y; Liu X; Qi Q; Xu J; Xu C; Shi S; Wang J; Liu T; Dong L Respir Res; 2024 Jun; 25(1):230. PubMed ID: 38824593 [TBL] [Abstract][Full Text] [Related]
34. Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling. Sun HF; Yang XL; Zhao Y; Tian Q; Chen MT; Zhao YY; Jin W Cancer Lett; 2019 Jan; 440-441():189-201. PubMed ID: 30393159 [TBL] [Abstract][Full Text] [Related]
35. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity. Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079 [TBL] [Abstract][Full Text] [Related]
36. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung. Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744 [TBL] [Abstract][Full Text] [Related]